cholangiocarcinoma
FDA approves Incyte’s Pemazyre for rare bile duct cancer
Richard Staines
bile duct cancer, cancer, cholangiocarcinoma, Incyte
0 Comment
X
FDA approves Incyte’s Pemazyre for rare bile duct cancer
https://pharmaphorum.com/news/fda-approves-incytes-pemazyre-for-rare-bile-duct-cancer/